drugset
drugset / Trial / NCT03245827

Hypogonadotropic Hypogonadism in Obese Young Males

NCT03245827 ↗

Phase 2 Terminated 9 enrolled Sandeep Singh Dhindsa, M.D., F.A.C.E
RandomizedParallel-groupDouble-blindTreatment

Summary

Obesity can lead to low testosterone concentrations in young men. This study will study the effects of low testosterone in those men and the result of treating them with clomiphene.

Timeline

Start
2019-04-01
Primary completion
2021-10-29
Completion
2021-10-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clomiphene Other / unclassified 25 mg —

Indications

hypogonadotropic hypogonadism